SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Galapagos Islands -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (38177)4/29/2003 10:21:22 AM
From: PuddleGlum  Respond to of 57110
 
MYGN has a good diagnostics segment, so they have income regardless of how the capital markets are doing. I think Greenlaw is off base on that one. CRA also has a fledgling diagnostics business that appears to be off to a good start (but years from profitability). However, they currently have no drugs in clinical trials, so drug money is a decade away for them.

I agree with you about the short term prospects for biotech.



To: tuck who wrote (38177)4/29/2003 10:39:04 AM
From: Jorj X Mckie  Read Replies (3) | Respond to of 57110
 
Well, I'm within pennies of my entry point, so I am going to ride it out here.

I am going to look more closely at HGSI and CRA. They were on my list anyway.

I am looking for a general downturn in the sector and in the markets, so...where's my dartboard....


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News